Lyell Immunopharma, Inc. (NASDAQ: LYEL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LYELL IMMUNOPHARMA, INC.

Lyell Immunopharma, Inc. (NASDAQ: LYEL)
Listen to this Section


$12.96
+0.3300 ( +2.61% ) 33.2K

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Market Data


Open $12.96
Previous Close $12.63
Volume 33.2K
Market Cap $294.71M
Day Range $12.43 - $13.74
52 Week Range $8.46 - $45.00
Shares Outstanding 23.33M
Change % +2.61%
Net Change ▲ 0.3300
Insider Ownership -0.03%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -9,580,000.00

Date Type Amount Purchased Purchaser
2024-06-17 Sale -130000.00 FRIEDMAN CATHY
2024-06-17 Sale -130000.00 BRAWLEY OTIS W
2024-06-17 Sale -130000.00 NABEL ELIZABETH G
2024-06-17 Sale -130000.00 RIEFLIN WILLIAM JL
2024-06-17 Sale -130000.00 Klausner Richard
2024-06-17 Sale -130000.00 NELSEN ROBERT
2023-11-20 Sale -500000.00 Hill Stephen J.
2023-11-20 Sale -7500000.00 Seely Lynn
2023-11-20 Sale -800000.00 Lee Gary K.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Aug 13, 2025
10-q Quarterly Reports 85 Aug 12, 2025
8-k 8K-related 14 Aug 12, 2025
4 Insider transactions 1 Jul 29, 2025
3 Insider transactions 1 Jul 29, 2025
8-k 8K-related 16 Jul 25, 2025
8-k 8K-related 12 Jun 26, 2025
8-k 8K-related 12 Jun 17, 2025
3 Insider transactions 2 Jun 11, 2025
3 Insider transactions 2 Jun 11, 2025

Latest News